Yan Wei Jie Wang
10.3343/alm.2013.33.1.86
Ann Lab Med
2013 Jan;33(1):86-8.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/23301230/
Bacterial Proteins / metabolism Citrobacter freundii / enzymology Plasmids / metabolism Respiratory Tract Infections / diagnosis beta-Lactamases / metabolism
Bacterial Proteins / metabolism Citrobacter freundii / enzymology Plasmids / metabolism Respiratory Tract Infections / diagnosis beta-Lactamases / metabolism Case Reports Letter Aged Anti-Bacterial Agents / pharmacology Anti-Bacterial Agents / therapeutic use Asian People Bacterial Proteins / genetics China Cilastatin / therapeutic use Cilastatin, Imipenem Drug Combination Citrobacter freundii / drug effects Citrobacter freundii / isolation & purification Drug Combinations Drug Resistance, Multiple, Bacterial Humans Imipenem / therapeutic use Male Microbial Sensitivity Tests Respiratory Tract Infections / drug therapy Respiratory Tract Infections / microbiology beta-Lactamases / genetics Anti-Bacterial Agents Bacterial Proteins Drug Combinations Cilastatin Imipenem Cilastatin, Imipenem Drug Combination AmpC beta-lactamases beta-Lactamases
PMC3535205
23301230
Identification of ACT-1 plasmid-mediated AmpC β-lactamase producing Citrobacter freundii from a Chinese patient
2013